Your session is about to expire
← Back to Search
Procedure
PEAL surgery for Urological Diseases
N/A
Waitlist Available
Research Sponsored by Loma Linda University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients undergoing laparoscopic urologic surgery
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 30 days postoperatively
Awards & highlights
Study Summary
This trial will study a new type of minimally-invasive surgery that uses small instruments.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 30 days postoperatively
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 30 days postoperatively
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Pain score of all surgical sites
Time to first opioid use
Total inpatient opioid dosage
Trial Design
1Treatment groups
Experimental Treatment
Group I: PEAL surgeryExperimental Treatment1 Intervention
Patients will undergo percutaneous externally-assembled laparoscopic surgery
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
PEAL surgery
2016
N/A
~10
Find a Location
Who is running the clinical trial?
Loma Linda UniversityLead Sponsor
306 Previous Clinical Trials
260,949 Total Patients Enrolled
Mohamed Keheila, MDStudy DirectorLoma Linda University Medical Center
2 Previous Clinical Trials
142 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger